Atlas Trials

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

Clinical trial NCT02527265 · COMPLETED

Trial details

NCT number
NCT02527265
Sponsor
Mannkind Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2017-09-28
Primary completion
2020-03-17
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.